With a $70 million expansion in Massachusetts, AbbVie plans the next phase of its US investment adventure

October 8, 2025

Gilead acquires San Diego start-up for early-stage cancer

May 13, 2023

Gilead and AI Drug Discovery Company Genesis Sign $35 Million Partnership

September 11, 2024

Must Read

Alector Ends Development of GSK-Partnered Latozinemab After Phase 3 Failure in FTD

October 22, 2025

FDA Expands Rybelsus Approval to Reduce Cardiovascular Risk in Type 2 Diabetes Patients

October 22, 2025

FDA Approves Roche’s Gazyva for Treatment of Active Lupus Nephritis

October 21, 2025

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Pfizer to Withdraw Vyndaqel in the U.S. Before Patent Expiration in 2028

Roche Ends Development of Obesity Candidate CT-173 and Discontinues Multiple Early-Stage Programs

$20 Million Pediatric CRISPR Center Launched to Develop Treatments for Rare Genetic Diseases

Scientists Identify New Target to Prevent Cancer from Spreading to Bones

Alector Ends Development of GSK-Partnered Latozinemab After Phase 3 Failure in FTD

Tvardi Therapeutics Reports Phase 2 Failure for IPF Drug Candidate TTI-101

Moderna Reveals Promising Melanoma Data Behind Decision to Proceed With Cancer Candidate

Amgen reports Vesalius-CV topline showing Repatha reduces MACE in primary-prevention patients

Johnson & Johnson to Spin Off Orthopedics Business as DePuy Synthes in 18 to 24 Months

AviadoBio Secures Option for $413 Million Gene Therapy Deal with UgeneX for Rare Eye Diseases

Novo Pens $5.2B Deal to Acquire Akero, Entering Liver Disease Space

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Reg impact assessment next in GenAI’s sights, experts claim

The now-urgent automation agenda: out-of-control regulatory workloads necessitate AI adoption

Improving life science R&D outcomes with AI

The medical device sector’s surging regulatory burden: how are suppliers coping?

James Riddle

Vaccine Hesitancy on the Rise: Here’s Why Vaccine Clinical Trial Process...

Editor Picks

With a $70 million expansion in Massachusetts, AbbVie plans the next phase of its US investment adventure

Gilead acquires San Diego start-up for early-stage cancer

Gilead and AI Drug Discovery Company Genesis Sign $35 Million Partnership

Must Read

Alector Ends Development of GSK-Partnered Latozinemab After Phase 3 Failure in FTD

FDA Expands Rybelsus Approval to Reduce Cardiovascular Risk in Type 2 Diabetes Patients

FDA Approves Roche’s Gazyva for Treatment of Active Lupus Nephritis

Hot Topics

About Us

Follow Us